Surmodics, Inc. (SRDX)

Surmodics Statistics

Total Valuation

Surmodics has a market cap or net worth of $561.15 million. The enterprise value is $550.59 million.

Market Cap	561.15M
Enterprise Value	550.59M

Important Dates

The last earnings date was Wednesday, November 6, 2024, before market open.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

Surmodics has 14.33 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	14.27M
Shares Outstanding	14.33M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	4.29%
Owned by Institutions (%)	76.27%
Float	12.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.40
Forward PS	3.94
PB Ratio	4.67
P/TBV Ratio	11.07
P/FCF Ratio	n/a
P/OCF Ratio	2,262.70
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.37
EV / EBITDA	81.34
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.25.

Current Ratio	3.96
Quick Ratio	3.08
Debt / Equity	0.25
Debt / EBITDA	4.37
Debt / FCF	n/a
Interest Coverage	-0.54

Financial Efficiency

Return on equity (ROE) is -9.67% and return on invested capital (ROIC) is -0.80%.

Return on Equity (ROE)	-9.67%
Return on Assets (ROA)	-0.66%
Return on Capital (ROIC)	-0.80%
Revenue Per Employee	$335,314
Profits Per Employee	-$30,697
Employee Count	376
Asset Turnover	0.69
Inventory Turnover	4.76

Taxes

In the past 12 months, Surmodics has paid $4.04 million in taxes.

Income Tax	4.04M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.63% in the last 52 weeks. The beta is 1.20, so Surmodics's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	+11.63%
50-Day Moving Average	38.49
200-Day Moving Average	36.27
Relative Strength Index (RSI)	63.40
Average Volume (20 Days)	227,374

Short Selling Information

The latest short interest is 330,948, so 2.31% of the outstanding shares have been sold short.

Short Interest	330,948
Short Previous Month	317,696
Short % of Shares Out	2.31%
Short % of Float	2.61%
Short Ratio (days to cover)	1.51

Income Statement

In the last 12 months, Surmodics had revenue of $126.08 million and -$11.54 million in losses. Loss per share was -$0.82.

Revenue	126.08M
Gross Profit	54.69M
Operating Income	-1.93M
Pretax Income	-9.16M
Net Income	-11.54M
EBITDA	6.77M
EBIT	-1.93M
Loss Per Share	-$0.82

Balance Sheet

The company has $40.11 million in cash and $29.55 million in debt, giving a net cash position of $10.56 million or $0.74 per share.

Cash & Cash Equivalents	40.11M
Total Debt	29.55M
Net Cash	10.56M
Net Cash Per Share	$0.74
Equity (Book Value)	118.90M
Book Value Per Share	8.38
Working Capital	60.76M

Cash Flow

In the last 12 months, operating cash flow was $248,000 and capital expenditures -$3.49 million, giving a free cash flow of -$3.24 million.

Operating Cash Flow	248,000
Capital Expenditures	-3.49M
Free Cash Flow	-3.24M
FCF Per Share	-$0.23

Margins

Gross margin is 43.38%, with operating and profit margins of -1.53% and -9.15%.

Gross Margin	43.38%
Operating Margin	-1.53%
Pretax Margin	-5.95%
Profit Margin	-9.15%
EBITDA Margin	5.37%
EBIT Margin	-1.53%
FCF Margin	-4.85%

Dividends & Yields

Surmodics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.87%
Shareholder Yield	-0.87%
Earnings Yield	-2.06%
FCF Yield	-0.58%

Analyst Forecast

The average price target for Surmodics is $43.00, which is 9.78% higher than the current price. The consensus rating is "Hold".

Price Target	$43.00
Price Target Difference	9.78%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 7, 2000. It was a forward split with a ratio of 2:1.

Last Split Date	Dec 7, 2000
Split Type	Forward
Split Ratio	2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	3